These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

897 related articles for article (PubMed ID: 32362243)

  • 21. Virtual screening and molecular simulation study of natural products database for lead identification of novel coronavirus main protease inhibitors.
    Tripathi N; Goel B; Bhardwaj N; Sahu B; Kumar H; Jain SK
    J Biomol Struct Dyn; 2022 May; 40(8):3655-3667. PubMed ID: 33213294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study.
    Das S; Sarmah S; Lyndem S; Singha Roy A
    J Biomol Struct Dyn; 2021 Jun; 39(9):3347-3357. PubMed ID: 32362245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repurposing drugs and identification of inhibitors of integral proteins (spike protein and main protease) of SARS-CoV-2.
    Shode FO; Idowu ASK; Uhomoibhi OJ; Sabiu S
    J Biomol Struct Dyn; 2022 Sep; 40(14):6587-6602. PubMed ID: 33590806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of potential inhibitors of SARS-CoV-2 main protease and spike receptor from 10 important spices through structure-based virtual screening and molecular dynamic study.
    Sen D; Debnath P; Debnath B; Bhaumik S; Debnath S
    J Biomol Struct Dyn; 2022 Feb; 40(2):941-962. PubMed ID: 32948116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computational discovery of small drug-like compounds as potential inhibitors of SARS-CoV-2 main protease.
    Andrianov AM; Kornoushenko YV; Karpenko AD; Bosko IP; Tuzikov AV
    J Biomol Struct Dyn; 2021 Sep; 39(15):5779-5791. PubMed ID: 32662333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation.
    Choudhary MI; Shaikh M; Tul-Wahab A; Ur-Rahman A
    PLoS One; 2020; 15(7):e0235030. PubMed ID: 32706783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of novel inhibitors of SARS-CoV-2 main protease (M
    Verma S; Patel CN; Chandra M
    J Comput Chem; 2021 Oct; 42(26):1861-1872. PubMed ID: 34287986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An investigation for the interaction of gamma oryzanol with the Mpro of SARS-CoV-2 to combat COVID-19: DFT, molecular docking, ADME and molecular dynamics simulations.
    Raman APS; Singh MB; Vishvakarma VK; Jain P; Kumar A; Sachdeva S; Kumari K; Singh P
    J Biomol Struct Dyn; 2023 Mar; 41(5):1919-1929. PubMed ID: 35067190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In silico screening of potential inhibitors from Cordyceps species against SARS-CoV-2 main protease.
    Deshmukh N; Talkal R; Lakshmi B
    J Biomol Struct Dyn; 2024 Jun; 42(9):4395-4411. PubMed ID: 37325819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of multiple SARS-CoV-2 proteins by an antiviral biomolecule, seselin from
    Nivetha R; Bhuvaragavan S; Muthu Kumar T; Ramanathan K; Janarthanan S
    J Biomol Struct Dyn; 2022; 40(21):11070-11081. PubMed ID: 34431451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive modeling by deep learning, virtual screening and molecular dynamics study of natural compounds against SARS-CoV-2 main protease.
    Joshi T; Joshi T; Pundir H; Sharma P; Mathpal S; Chandra S
    J Biomol Struct Dyn; 2021 Oct; 39(17):6728-6746. PubMed ID: 32752947
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Rout J; Swain BC; Tripathy U
    J Biomol Struct Dyn; 2022 Feb; 40(2):860-874. PubMed ID: 32938313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insight into crystal structures and identification of potential styrylthieno[2,3-
    El Bakri Y; Ahmad B; Saravanan K; Ahmad I; Bakhite EA; Younis O; Al-Waleedy SAH; Ibrahim OF; Nafady A; Mague JT; Mohamed SK
    J Biomol Struct Dyn; 2024 May; 42(8):4325-4343. PubMed ID: 37318002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 proteases Mpro and PLpro: Design of inhibitors with predicted high potency and low mammalian toxicity using artificial neural networks, ligand-protein docking, molecular dynamics simulations, and ADMET calculations.
    Tumskiy RS; Tumskaia AV; Klochkova IN; Richardson RJ
    Comput Biol Med; 2023 Feb; 153():106449. PubMed ID: 36586228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of polyphenols from
    Ghosh R; Chakraborty A; Biswas A; Chowdhuri S
    J Biomol Struct Dyn; 2021 Oct; 39(17):6747-6760. PubMed ID: 32762411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug repurposing studies targeting SARS-CoV-2: an ensemble docking approach on drug target 3C-like protease (3CL
    Koulgi S; Jani V; Uppuladinne M; Sonavane U; Nath AK; Darbari H; Joshi R
    J Biomol Struct Dyn; 2021 Sep; 39(15):5735-5755. PubMed ID: 32679006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors.
    Ibrahim MAA; Abdelrahman AHM; Hussien TA; Badr EAA; Mohamed TA; El-Seedi HR; Pare PW; Efferth T; Hegazy MF
    Comput Biol Med; 2020 Nov; 126():104046. PubMed ID: 33065388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening of plant-based natural compounds as a potential COVID-19 main protease inhibitor: an
    Majumder R; Mandal M
    J Biomol Struct Dyn; 2022 Feb; 40(2):696-711. PubMed ID: 32897138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An
    Clemente CM; Freiberger MI; Ravetti S; Beltramo DM; Garro AG
    J Biomol Struct Dyn; 2022 Aug; 40(12):5653-5664. PubMed ID: 33459192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined molecular docking and dynamics simulations studies of natural compounds as potent inhibitors against SARS-CoV-2 main protease.
    Ouassaf M; Belaidi S; Chtita S; Lanez T; Abul Qais F; Md Amiruddin H
    J Biomol Struct Dyn; 2022; 40(21):11264-11273. PubMed ID: 34315340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.